{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:13:43Z","timestamp":1793171623274,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T00:00:00Z","timestamp":1337817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0037989","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T21:13:43Z","timestamp":1337894023000},"page":"e37989","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP3 Receptors"],"prefix":"10.1371","volume":"7","author":[{"given":"Tamaki","family":"Ishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca<sup>2+<\/sup> signaling and cell survival.","volume":"131","author":"T Hayashi","year":"2007","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728222.12.1.45","article-title":"An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma-1 receptor ligand.","volume":"12","author":"T Hayashi","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1517\/14728222.2011.560837","article-title":"Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.","volume":"15","author":"T Hayashi","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors.","volume":"124","author":"T Maurice","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-0173(01)00112-6","article-title":"The interaction between neuroactive steroids and the sigma-1 receptor function: behavioral consequences and therapeutic opportunities.","volume":"37","author":"T Maurice","year":"2001","journal-title":"Brain Res Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1871524910909030197","article-title":"Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship.","volume":"9","author":"K Hashimoto","year":"2009","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/187152709789824633","article-title":"Can sigma-1 receptor agonist fluvoxamine prevent schizophrenia?","volume":"8","author":"K Hashimoto","year":"2009","journal-title":"CNS & Neurological Disorders - Drug Targets"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.npp.1301047","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.","volume":"32","author":"K Hashimoto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.2174\/138161206778559614","article-title":"Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.","volume":"12","author":"K Hashimoto","year":"2006","journal-title":"Curr Pharm Des"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hup.1106","article-title":"Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered.","volume":"25","author":"I Hindmarch","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"ref11","first-page":"25","article-title":"The role of sigma-1 receptors in the pathophysiology of neuropsychiatric diseases.","volume":"3","author":"M Ishikawa","year":"2010","journal-title":"J Receptor Ligand Channel Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1254\/jphs.CR0050032","article-title":"The sigma-1 protein as a target for the non-genomic effects of neuro(active)steroids: molecular, physiological, and behavioral aspects.","volume":"100","author":"FP Monnet","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2174\/138161212799436476","article-title":"Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases.","volume":"18","author":"T Niitsu","year":"2012","journal-title":"Curr Pham Des"},{"key":"ref14","article-title":"Recent advances in the potential therapeutic drugs for cognitive deficits in schizophrenia.","author":"T Yoshida","year":"2012","journal-title":"Curr Psychiatry Rev"},{"key":"ref15","article-title":"Sigma-1 receptor agonist fluvoxamine for delirium in elderly adults.","author":"K Hashimoto","year":"2012","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1124\/jpet.102.041970","article-title":"Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants.","volume":"303","author":"M Takebayashi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e2558","DOI":"10.1371\/journal.pone.0002558","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.","volume":"3","author":"T Nishimura","year":"2008","journal-title":"PLoS ONE"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.pnpbp.2008.06.011","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP<sub>3<\/sub> receptors.","volume":"32","author":"T Ishima","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1389450013348489","article-title":"Ifenprodil, a novel NMDA receptor antagonist: site and mechanisms of action.","volume":"2","author":"K Williams","year":"2001","journal-title":"Curr Drug Targets"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2009.00304.x","article-title":"Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.","volume":"157","author":"L Mony","year":"2009","journal-title":"Bri J Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(93)90241-9","article-title":"Further characterization of [<sup>3<\/sup>H]ifenprodil binding to sigma receptors in rat brain.","volume":"236","author":"K Hashimoto","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0922-4106(94)90211-9","article-title":"Further characterization of [<sup>3<\/sup>H]ifenprodil binding in rat brain.","volume":"266","author":"K Hashimoto","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(94)00763-W","article-title":"Interactions of <italic>erythro<\/italic>-ifenprodil, <italic>threo<\/italic>-ifenprodil, <italic>erythro<\/italic>-iodoifenprodil, and eliprodil with subtypes of sigma receptors.","volume":"273","author":"K Hashimoto","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ntt.2004.02.006","article-title":"Assessment of PC12 cell differentiation and neurite growth: A comparison of morphological and neurochemical measures.","volume":"26","author":"KP Das","year":"2004","journal-title":"Neurotoxicol Teratol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1527-3458.1996.tb00299.x","article-title":"NE-100: A novel sigma receptor antagonist.","volume":"2","author":"S Okuyama","year":"1996","journal-title":"CNS Drug Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0091-3057(00)00405-6","article-title":"Pharmacologixcal identification of SM-21, the novel sigma-2 antagonist.","volume":"67","author":"C Ghelardini","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1046\/j.1471-4159.1998.70052147.x","article-title":"In vitro binding properties in rat brain of [<sup>3<\/sup>H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits.","volume":"70","author":"V Mutel","year":"1998","journal-title":"J Neurochem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0896-6273(00)80384-0","article-title":"Xestospongins: potent membrane permeable blockers of the inositol 1,4,5-trisphosphate receptor.","volume":"19","author":"J Gafni","year":"1997","journal-title":"Neuron"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/oxfordjournals.jbchem.a021780","article-title":"2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of ins (1,4,5)P3-induced Ca<sup>2+<\/sup> release.","volume":"122","author":"T Maruyama","year":"1997","journal-title":"J Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1126\/science.287.5458.1647","article-title":"Requirement of the inositol trisphosphate receptor for activation of store-operated Ca<sup>2+<\/sup> channels.","volume":"287","author":"HT Ma","year":"2000","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1083\/jcb.119.4.883","article-title":"Calcium influx into neurons can solely account for cell contact-dependent neurite outgrowth stimulated by transfected L1.","volume":"119","author":"EJ Williams","year":"1992","journal-title":"J Cell Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/tx200160g","article-title":"The pivotal role of intracellular calcium in oxaliplatin-induced inhibition of neurite outgrowth but not cell death in differentiated PC12 cells.","volume":"24","author":"M Takeshita","year":"2011","journal-title":"Chem Res Toxicol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.biopsych.2011.10.014","article-title":"Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse.","volume":"71","author":"A Kishimoto","year":"2012","journal-title":"Biol Psychiatry"},{"key":"ref34","first-page":"274","article-title":"Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation.","volume":"4","author":"RA Chambers","year":"1999","journal-title":"Semin Clin Neuropsychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1017\/S1092852900010427","article-title":"The role of glutamate in anxiety and related disorders.","volume":"10","author":"BM Cortese","year":"2005","journal-title":"CNS Spectr"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainres.2010.12.075","article-title":"Potentiation of NGF-induced neurite outgrowth in PC12 cells by papaverine: Role played by PLC-\u03b3, IP<sub>3<\/sub> receptors.","volume":"1377","author":"K Itoh","year":"2011","journal-title":"Brain Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2010.09.007","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: A possible role of IP<sub>3<\/sub> receptors.","volume":"648","author":"T Minase","year":"2010","journal-title":"Eur J Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0037989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T23:55:08Z","timestamp":1588982108000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0037989"}},"subtitle":[],"editor":[{"given":"Alexander G.","family":"Obukhov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0037989","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}